书签 分享 收藏 举报 版权申诉 / 3
1

类型[20210211]IF11056_处方药进口.pdf

  • 上传人:任**
  • 文档编号:30294
  • 上传时间:2022-06-24
  • 发布时间:2021-02-11
  • 格式:PDF
  • 页数:3
  • 大小:519.22KB
  • https:/crsreports.congress.gov Updated February 11, 2021Prescription Drug ImportationIn the context of rising drug prices, the possibility of importing prescription drugs from other countries at lower prices is again being debated. Generally, the importation or reimportation of a prescription drug that does not meet Food and Drug Administration (FDA) requirements is prohibited. The policy debate has centered on creating a new legal option for the import of prescription drugs into the United States at lower cost than the same drugs available domestically. Prescription Drug Regulation FDA, under the Federal Food, Drug, and Cosmetic Act (FFDCA), regulates prescription drugs. In order to market a new drug in the United States, a manufacturer must obtain approval from FDA by submitting a new drug application (NDA), or in the case of a generic drug, an abbreviated NDA (ANDA). To get approval, the manufacturer must (1) demonstrate the drugs safety and effectiveness according to criteria specified in law and regulation, (2) ensure that its manufacturing facility passes FDA inspection, and (3) obtain approval for the drugs labeling. Drugs made in foreign countries that are imported into th
    展开阅读全文
    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    20210211 IF11056_ 处方药 进口
    1
    提示  联参智库所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
    关于本文
    本文标题:[20210211]IF11056_处方药进口.pdf
    链接地址:https://www.lianhezuozhan.com/doc/30294.html
    1

    客服:010-66465788   北京联参科技有限公司版权所有  工业和信息化部备案/许可证编号:京ICP备2022007273号-1



    联参智库